As for systemic inflammation, we have recently shown that OPG delivery increases IL-6, MCP-1, and TNF-α circulating levels [77], which is consistent with the view that it takes part in the pathogenesis of atherosclerosis and CVD by amplifying inflammation [5]. Here, TNFRSF11B is linked to atherosclerosis.